Regulatory Challenges in Clinical Cancer Drug Development
16 September 2024, 08:30-10:00 CET
CC5 – Zaragoza Auditorium, Barcelona, ES
The CDDF and ESMO will hold a joint session on “Regulatory Challenges in Clinical Cancer Drug Development” on Monday 16 September from 8:30 to 10:00 AM (CET) at CC5 – Zaragoza Auditorium during the ESMO Congress 2024 in Barcelona, Spain.
SESSION CHAIRS
- Ruth Plummer (CDDF & Newcastle University, UK)
- Jean-Yves Blay (ESMO, FR)
AGENDA: (CET time zone)
08:30 – 08:50 Specifics of CHMP assessment of cancer drugs – Aaron E. Sosa Mejia (Danish Medicines Agency)
08:50 – 09:10 Current status and implications of the In Vitro Diagnostics regulation – Audrey Wolf (EFPIA, BE)
09:10 – 09:30 Initiatives for a joint EU HTA assessment – Marcus Guardian (Dierks+Company, BE)
09:30 – 10:00 Q&A and discussion